Financials
- Market Capitalization 265.09 M
- Employee 43
- Founded 2015
- CEO N/A
- Website www.alxoncology.com
- Headquarter Delaware, United States
- FIGI BBG00VR8SDG8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.59
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3402 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.47 USD | +2.36% | -1.70% | -0.29% | -30.32% | 276.37 M USD | ||
| 3413 | GLSI Greenwich LifeSciences, Inc. - Common stock | 18.57 USD | -6.21% | -9.59% | -23.96% | +73.71% | 272.57 M USD | ||
| 3431 | SRZN Surrozen, Inc. - Common Stock | 22.81 USD | -1.64% | -3.22% | -4.88% | +168.04% | 264.83 M USD | ||
| 3455 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.96 USD | -3.92% | -1.01% | +15.29% | +1.03% | 258.78 M USD |